TB-500 distributes broadly through connective tissue, muscles, and joints throughout the body, which makes it particularly useful for patients dealing with multiple injury sites, diffuse connective tissue inflammation, or slower-healing chronic conditions that a localized peptide cannot fully address
If your insurance company stops covering your medication, contact your healthcare provider immediately so they can initiate the appeals process

Important considerations include: GLP-1 agonists are generally well-tolerated in people with hypertension They do not typically cause dangerous drops in blood pressure Dehydration from gastrointestinal side effects (nausea, vomiting, diarrhoea) can occasionally affect blood pressure and kidney function, so maintaining adequate fluid intake is important If you take diuretics (water tablets), ACE inhibitors or ARBs for blood pressure, your doctor may monitor you more closely during the initial weeks of GLP-1 therapy Seek medical advice promptly if you experience persistent gastrointestinal symptoms that prevent adequate fluid intake NICE guidance (NG28) supports the use of GLP-1 agonists in people with type 2 diabetes who meet specific criteria, with preference for agents with proven cardiovascular benefits in those with established cardiovascular disease
Wound & tissue repair Investigated in animal and cell-culture research on wound healing and connective-tissue repair
Copper GHK is an oral liposomal copper tripeptide complex, GHK-Cu, designed to replenish endogenous GHK-Cu to more youthful levels